Table 3. Mortality and pneumonia among patients with COVID-19 according to the period between initial symptoms and clinical progression to COVID-19 suspicion (PISYCS).
| Variable | Mortality | Pneumonia | ||||
|---|---|---|---|---|---|---|
| All Patients (N = 65,500) | ||||||
| PISYCS (N) | %* | OR (95% CI) | p-value | %* | OR (95% CI) | p-value |
| < 24 Hours (9759) | 5.2% | 1.75 (1.55–1.98) | <0.001 | 22.5% | 1.49 (1.39–1.58) | <0.001 |
| 1–3 Days (28331) | 2.5% | 1 | 1 | 14% | 1 | 1 |
| 4–7 Days (20877) | 3.6% | 1.53 (1.37–1.70) | <0.001 | 19.5 | 1.48 (1.41–1.56) | <0.001 |
| > 7 Days (6533) | 4.1% | 1.67 (1.44–1.94) | <0.001 | 20.6% | 1.57 (1.46–1.69) | <0.001 |
| “p value” | <0.001 | <0.001 | ||||
| SUBGROUP ANALYSIS | ||||||
| Positive Test (N = 13,842) | ||||||
| PISYCS | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| < 24 Hours | 2.11 (1.75–2.55) | <0.001 | 1.66 (1.45–1.90) | <0.001 | ||
| 1–3 Days | 1 | 1 | 1 | 1 | ||
| 4–7 Days | 1.42 (1.22–1.65) | <0.001 | 1.69 (1.53–1.85) | <0.001 | ||
| > 7 Days | 1.22 (1.00–1.49) | 0.053 | 1.83 (1.62–2.07) | <0.001 | ||
| Negative Test (N = 43,419) | ||||||
| PISYCS | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| < 24 Hours | 1.55 (1.29–1.86) | <0.001 | 1.58 (1.46–1.70) | <0.001 | ||
| 1–3 Days | 1 | 1 | 1 | 1 | ||
| 4–7 Days | 1.00 (0.83–1.21) | 0.967 | 1.10 (1.01–1.16) | 0.038 | ||
| > 7 Days | 1.39 (1.10–1.81) | 0.014 | 1.11 (1.00–1.24) | 0.061 | ||
| Test Result Pending (N = 8,239) | ||||||
| PISYCS | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| < 24 Hours | 1.41 (0.68–2.90) | 0.357 | 0.80 (0.64–0.99) | 0.043 | ||
| 1–3 Days | 1 | 1 | 1 | 1 | ||
| 4–7 Days | 1.22 (0.70–2.13) | 0.484 | 2.03 (1.77–2.34) | <0.001 | ||
| > 7 Days | 1.71 (0.78–3.74) | 0.182 | 1.96 (1.57–2.44) | <0.001 | ||